Newsroom - Taj Pharma (Oncology)
Pharma Industry News
The latest Pharma Industry News & articles published daily. Includes news on pharmaceutical companies, mergers and acquisitions, drug development, export and import of drugs, legislation, advertising and influence.
Taj Pharma offers accurate, readable and informative news reports every day.
- Examines International Fight Against H1N1
- New drug regulatory norms on cards
- Human clinical trials must be registered
- FDA Issues Public Health Notification On Glucose Monitoring Technology
- The Dreaded Hangover: Asparagus Extracts May Protect The Liver
- California Medical Association Responds To Recent Remarks By President Obama
What Is Nutrition? Why Is Nutrition Important?
Nutrition, nourishment, or aliment, is the supply of materials - food - required by organisms and cells to stay alive. In science and human medicine, nutrition is the science or practice of consuming and utilizing foods
International Travel Health Guidebook
If you are an international traveler, the U.S. government has a guidebook that could save your life. The U.S. Centers for Disease Control and Prevention has released a new edition of CDC Health Information for International
Conditional Relative Survival Of Cancer Patients And Conditional Probability Of Death
Patients often ask at what milestone year after treatment for cancer they might consider their risk to be minimal for a recurrence. This time point decreases much of the anxiety patients live with
GSK Unveils Update On H1N1 Influenza Vaccine
Company has started clinical development program for its adjuvant pandemic vaccine
Abbott Expands XIENCE V(R) USA Trial
To Enroll Patients Into Landmark Dual Anti-Platelet Therapy (DAPT) Trial
Taj Pharma Group
A dream for new world Anchored in India and committed to its traditional values of leadership with trust, the Taj Pharma Group is spreading its footprint globally through excellence and innovation.
Each operating company in the group develops its international business as an integral element in an overall strategy, depending on the competitive dynamics of the industry in which it operates. For some businesses a focus on the export market remains the priority. For others it is developing a robust presence in domestic markets given growing population of India. And then there are Group companies, a small but growing number, that have global ambitions; additionally, synchronizing these ventures to cater Indian market remains a priority for growth.
Exports from India remain the cornerstone of the Taj Pharma Group’s international business, but different Taj companies are increasingly investing in assets overseas through Greenfield projects (such as in Spain, Germany, Middle East, Africa, Russia, and CIS Countries), joint ventures (in Sri Lanka, UK) and acquisitions.
While individual Taj companies have differing geographical imperatives, the Taj group is focusing on a clutch of priority countries, which are expected to be of strategic importance in the years ahead. The regions are UK, Sri Lanka, the Netherlands, Germany, South Africa, members of the Gulf Cooperation Council, Brazil, Vietnam, Thailand and Taiwan.
Dr. R.K.Singh, Chairman, Taj Pharmaceuticals Limited., sums up the Taj group’s efforts to internationalize its operations thus: “We hope that a several years from now we will spread our wings far beyond India, that we become a global group, operating in many countries, an Indian business conglomerate that is at home in the world, carrying the same sense of trust that we do today." We have already progressed on such efforts by our current presence in more than 40 countries.